pharmaceutical industry

The lawsuit alleges that the drug makers shifted customers to a new form of the drug to block generic competitors.

The Hunt Valley drug developer and manufacturer will use the equity and debt refinancing investment to advance its drug formulation capabilities and upgrade manufacturing operations.

In the midst of the ongoing debate about soaring drug prices, there is one voice that is too rarely heard — the patient voice. As the ones depending on these drugs each and every day, patients must be considered first and foremost. Who speaks for us? Certainly it isn't the insurers who fight filling our prescriptions for medications deemed vital by our doctors. Supposedly it is the job of the insurance companies to facilitate access to these medications, but that is not what is happening.

EpiPens needed by those with severe food allergies are getting expensive

Asthma-related hospitalizations increase significantly during severe heat and rainstorms, which are predicted to worsen as the Earth warms from climate change, according to new research from the University of Maryland School of Public Health.

Amid controversy over alleged mislabeling of olive oil, the U.S. Food and Drug Administration is being asked to test imports to look for unpure or misbranded products.

The pills are responsible for numerous deaths and non-fatal overdoses nationwide, including in Carroll County.

Losses continued to mount at Cerecor, a Baltimore pharmaceutical company, as it continues to develop and test a new antidepressant and other drugs.

High prescription drug prices make most Americans' blood boil, with the same drugs costing up to six times more here than in Western Europe, where drug prices are regulated. However, one cause of high prices has received scant attention: the delays in bringing generic drugs to the market.

The firm last has released what it believes is breakthrough technology designed to save time pharmacists while improving dispensing accuracy. The "FlavorMaster," billed as the first fully automated device of its kind, can add flavor as well as water to reconstitute powdered medicine.

Over 80 percent of the patients we see at Bon Secours are covered by Medicare or Medicaid, or they are uninsured. To provide the medical attention our patients need, we deliver a great deal of uncompensated care, which 340B helps us sustain. Without this program, which some drugmakers are pressuring Congress to scale back, those with the greatest need could lose critical services, and our efforts to serve all of our patients with the best care possible would be compromised.

Shares of Columbia-based Osiris Therapeutics were down more than 12 percent Thursday afternoon after the regenerative medicine company announced the resignation of CEO Lode Debrabandere for personal reasons.

Bills could expand prescription drug tracking, opportunity to prosecute trafficking

The Annapolis biopharmaceutical company PharmAthene has won a court victory that could bring it more than $200 million from a rival company that was once planning to be its partner in developing a treatment for smallpox

Researchers at Frostburg State University and the University of Maryland, Eastern Shore have formed partnerships with medical marijuana companies to study the science behind using pot as medicine.

Shares in Cerecor Inc. are up 25 percent since the Baltimore-based pharmaceutical company announced it was replacing its president and CEO.

WellDoc, a Baltimore health information technology firm, raised $22 million from a second round of venture capital investment to commercialize its diabetes management application.

Only the feds can solve the problem of high prescription drug prices

Giant pharmaceutical maker uses merger to avoid taxes, boost profits and hurt consumers

Treat drug companies like public utilities and the days of $750 pills will be over

The planned merger of Walgreens and Rite Aid will leave just two mega drugstore chains in the Baltimore area and across the U.S.

The shocking case of Daraprim — and other drugs like it — highlights the need for a national law to prohibit pharmaceutical price gouging.

Cerecor, a Baltimore pharmaceutical company testing an antidepressant for patients who are not responding to other drugs, raised $26 million in an initial public stock offering Thursday.

Cerecor, a Baltimore pharmaceutical company planning an initial public stock offering, has launched a new study of an antidepressant it says can help patients who aren't responding to standard treatments.

AstraZeneca and its global biologics research and development arm, MedImmune, along with BioHealth Innovation and the Tech Council of Maryland have committed to developing and supporting a strategic plan that will leverage our region's intellectual capital and accelerate the commercialization of new research through collaborative efforts. Our goal is to place the Maryland region among the top three biotech hubs in the U.S. by 2023.

Congress should not allow e-cigarettes to duck federal regulations

Simple tests already used regularly to assess kidney function and damage could also help doctors predict who will suffer heart disease, researchers from Johns Hopkins Bloomberg School of Public Health have found.

Pharmacy chain Rite Aid released a statement Wednesday warning that customers with prescriptions in Baltimore stores looted during recent unrest in the city may have had their personal medical information stolen.

The Medical Innovation Act would give the NIH a funding boost by forcing large pharmaceutical companies that have committed wrongdoing to support the NIH. The bill would ask these companies to pay a relatively small additional sum into NIH research after they enter into settlement agreements with the government.

The crash of Germanwings Flight 9525, allegedly by co-pilot Andreas Lubitz and the deaths of all 150 people on board is indeed a tragedy. But some good may come out of it if it induces people to take another look at those substances the pharmaceutical industry calls "antidepressants."

British drug maker GlaxoSmithKline is establishing a vaccine research center in Rockville that it expects will bring 600 jobs to the state.

The Food and Drug Administration on Tuesday approved Cholbam, developed by Baltimore biotechnology company Asklepion Pharmaceuticals, for treatment of a rare disease that prevents people from making key digestive acids.

Gaithersburg-based MedImmune has signed a flurry of partnerships with National Institutes of Health labs in hopes of speeding scientific discoveries and growing the region into a major biotechnology hub.

The health care law that was supposed to make insurance available to hundreds of thousands in the state is costing Marylanders so much in prescription drug costs that it may deter patients from taking their medicine, the survey by the Partnership to Fight Chronic Disease found.

Business advocates said they were relieved that cuts to Maryland economic development programs weren't deeper in Gov. Larry Hogan's first budget.

Drug company payments to doctors are a small part of a much larger strategy by Big Pharma to clean our pockets.

Federal database shows $3.5 billion paid by health care industry to doctors in 5 months for clinical trials, consulting and other services

Focus of prescription drug collection day has turned to treatment and prevention, and away from law enforcement, officials say

A compound created at the University of Maryland School of Medicine is showing great promise in clinical trials as a drug to fight prostate cancer.

The number of drug overdoses related to heroin and prescription painkillers in Howard County is rapidly on the rise: a trend that has led the county Health Department to launch a series of initiatives aimed at reducing incidents.

An alarming spike in heroin and other drug overdose deaths in Maryland has prompted what the state's health secretary calls an "all hands on deck" effort to investigate and treat addiction.

Health care providers have the tools to help mentally ill — if the laws allow it

With Triple Crown season upon us, we are calling on Congress to pass the Horseracing Integrity and Safety Act to protect the sport's athletes — both equine and human — and begin to restore integrity and confidence in an industry whose reputation has been badly sullied.

Baltimore's success in reducing cases of tuberculosis could be eroded as budget cuts make monitoring the stubbornly persistent health threat more difficult as new sources and more drug-resistant strains emerge.

A settlement was filed in bankruptcy court Tuesday that could provide victims of a nationwide meningitis outbreak linked to tainted steroid injections with $100 million as early as next year, lawyers said.

Drugs continue to be Harford's biggest problem, and legalizing any of them would only make things worse, Harford County Sheriff Jesse Bane said.

Given the amount of drugs collected at take back days in Harford County since their inception, it seems like it would make sense to provide such a service at health department buildings and police stations.